Organometallic ruthenium(II)-arene complexes are currently attracting increasing interest as anticancer compounds with the potential to overcome drawbacks of traditional drugs like cisplatin with respect to resistance, selectivity, and toxicity. Rational design of new potential
pharmaceutical compounds requires a detailed understanding of structure–property relationships at an atomic level. We performed in vacuo density functional theory(DFT) calculations, classical MD, and mixed QM/MM Car-Parrinello MD explicit solvent simulations to rationalize the
binding mode of two series of anticancer ruthenium(II) arene complexes to double-stranded DNA (dsDNA).Binding energies between the metal centers and the surrounding ligands as well as proton affinities were calculated using DFT. Our results support a pH-dependent mechanism for the activity
of the RAPTA [Ru(η6-arene)X2(pta)] (pta = 1,3,5-triaza-7-phosphatricyclo[126.96.36.199]decane) compounds. Adducts of the bifunctional RAPTA and themonofunctional [Ru(η6-p-cymene)Xen]+ series of compounds with the DNA sequence d(CCTCTG*G*TCTCC)/d(GGAGACCAGAGG),
where G* are guanosine bases that bind to the ruthenium compounds through their N(7) atom, have been investigated. The resulting binding sites were characterized in QM/MM molecular dynamics simulations showing that DNA can easily adapt to accommodate the ruthenium compounds.
No Supplementary Data.
No Article Media
Document Type: Research Article
March 1, 2005
More about this publication?
International Journal for Chemistry and Official Membership Journal of the Swiss Chemical Society (SCS) and its Divisions
CHIMIA, a scientific journal for chemistry in the broadest sense, is published 10 times a year and covers the interests of a wide and diverse readership. Contributions from all fields of chemistry and related areas are considered for publication in the form of Review Articles and Notes. A characteristic feature of CHIMIA are the thematic issues, each devoted to an area of great current significance.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Information for Advertisers
- Ingenta Connect is not responsible for the content or availability of external websites